HELIX Financial Statements From 2010 to 2024
| HBP Stock | EUR 1.15 0.00 0.00% |
Check HELIX BIOPHARMA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HELIX BIOPHARMA's main balance sheet or income statement drivers, such as , as well as many indicators such as . HELIX financial statements analysis is a perfect complement when working with HELIX BIOPHARMA Valuation or Volatility modules.
HELIX |
HELIX BIOPHARMA Company EBITDA Analysis
HELIX BIOPHARMA's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current HELIX BIOPHARMA EBITDA | (6.53 M) |
Most of HELIX BIOPHARMA's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HELIX BIOPHARMA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, HELIX BIOPHARMA reported earnings before interest,tax, depreciation and amortization of (6.53 Million). This is much lower than that of the Other sector and significantly lower than that of the Other industry. The ebitda for all Germany stocks is notably higher than that of the company.
HELIX BIOPHARMA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HELIX BIOPHARMA's current stock value. Our valuation model uses many indicators to compare HELIX BIOPHARMA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HELIX BIOPHARMA competition to find correlations between indicators driving HELIX BIOPHARMA's intrinsic value. More Info.HELIX BIOPHARMA is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in price to book category among its peers . The ratio of Current Valuation to Price To Book for HELIX BIOPHARMA is about 572,489 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HELIX BIOPHARMA's earnings, one of the primary drivers of an investment's value.About HELIX BIOPHARMA Financial Statements
HELIX BIOPHARMA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although HELIX BIOPHARMA investors may analyze each financial statement separately, they are all interrelated. The changes in HELIX BIOPHARMA's assets and liabilities, for example, are also reflected in the revenues and expenses on on HELIX BIOPHARMA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for HELIX Stock Analysis
When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.